These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 1444106)
1. [Primary cutaneous lymphoma, with the exception of mycosis fungoides]. Joly P; Charlotte F; Leibowitch M; Haioun C; Wechsler J; Dreyfus F; Escande JP; Revuz J; Bagot M Ann Dermatol Venereol; 1992; 119(6-7):457-62. PubMed ID: 1444106 [TBL] [Abstract][Full Text] [Related]
2. Cutaneous lymphomas other than mycosis fungoides: follow-up study of 52 patients. Joly P; Charlotte F; Leibowitch M; Haioun C; Wechsler J; Dreyfus F; Escande JP; Revuz J; Reyes F; Varet B J Clin Oncol; 1991 Nov; 9(11):1994-2001. PubMed ID: 1941058 [TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma. Beljaards RC; Meijer CJ; Van der Putte SC; Hollema H; Geerts ML; Bezemer PD; Willemze R J Pathol; 1994 Jan; 172(1):53-60. PubMed ID: 7931828 [TBL] [Abstract][Full Text] [Related]
4. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma. Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274 [TBL] [Abstract][Full Text] [Related]
5. Survival data for 299 patients with primary cutaneous lymphomas: a monocentre study. Hallermann C; Niermann C; Fischer RJ; Schulze HJ Acta Derm Venereol; 2011 Sep; 91(5):521-5. PubMed ID: 21547335 [TBL] [Abstract][Full Text] [Related]
6. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383 [TBL] [Abstract][Full Text] [Related]
8. [Prognosis of primary cutaneous lymphomas]. Grange F; Bagot M Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):30-40. PubMed ID: 11937927 [TBL] [Abstract][Full Text] [Related]
9. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases. Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346 [TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome. Garcia-Herrera A; Colomo L; Camós M; Carreras J; Balague O; Martinez A; Lopéz-Guillermo A; Estrach T; Campo E J Clin Oncol; 2008 Jul; 26(20):3364-71. PubMed ID: 18541895 [TBL] [Abstract][Full Text] [Related]
11. Full clinical recovery after topical acyclovir treatment of Epstein-Barr virus associated cutaneous B-cell lymphoma in patient with mycosis fungoides. Copur MS; Deshpande A; Mleczko K; Norvell M; Hrnicek GJ; Woodward S; Frankforter S; Mandolfo N; Fu K; Chan WC Croat Med J; 2005 Jun; 46(3):458-62. PubMed ID: 15861527 [TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases. Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomas. Tancrède-Bohin E; Ionescu MA; de La Salmonière P; Dupuy A; Rivet J; Rybojad M; Dubertret L; Bachelez H; Lebbé C; Morel P Arch Dermatol; 2004 Sep; 140(9):1057-61. PubMed ID: 15381544 [TBL] [Abstract][Full Text] [Related]
16. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas. Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809 [TBL] [Abstract][Full Text] [Related]
17. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group. Senff NJ; Willemze R Br J Dermatol; 2007 Dec; 157(6):1205-11. PubMed ID: 17941944 [TBL] [Abstract][Full Text] [Related]
18. Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients. Beal K; Allen L; Yahalom J Cancer; 2006 Jun; 106(12):2652-6. PubMed ID: 16700039 [TBL] [Abstract][Full Text] [Related]
19. The spectrum of cutaneous lymphomas in Japan: a study of 62 cases based on the World Health Organization Classification. Yasukawa K; Kato N; Kodama K; Hamasaka A; Hata H J Cutan Pathol; 2006 Jul; 33(7):487-91. PubMed ID: 16872471 [TBL] [Abstract][Full Text] [Related]
20. Mycosis fungoides associated with B-cell malignancies. Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]